190 related articles for article (PubMed ID: 4696355)
21. [Atypical malignant hyperthermia].
Matsubara I; Sumiya T; Yoshimura T; Yamazaki R; Kubota M; Goto Y
Masui; 1983 Mar; 32(3):339-42. PubMed ID: 6864998
[No Abstract] [Full Text] [Related]
22. Clinical and genetic aspects of malignant hyperpyrexia.
Kyei-Mensah K; Tyrrell JH; Sumner DW
Proc R Soc Med; 1973 Jan; 66(1 Pt 1):63-6. PubMed ID: 4690060
[No Abstract] [Full Text] [Related]
23. [Malignant hyperthermia due to general anesthesia. Diagnosis and treatment].
Böttger P; Doehn M; Horatz K; Kessler G
Anasthesiol Intensivmed Prax; 1975; 10(1):13-6. PubMed ID: 1163751
[No Abstract] [Full Text] [Related]
24. Malignant hyperpyrexia: successful management following oral surgery.
Forman G
Br J Oral Surg; 1980 Sep; 18(2):107-11. PubMed ID: 6934802
[TBL] [Abstract][Full Text] [Related]
25. Halothane-succinylcholine induced masseter spasm: indicative of malignant hyperthermia susceptibility?
Flewellen EH; Nelson TE
Anesth Analg; 1984 Jul; 63(7):693-7. PubMed ID: 6731899
[No Abstract] [Full Text] [Related]
26. Masseter spasm with anesthesia: incidence and implications.
Schwartz L; Rockoff MA; Koka BV
Anesthesiology; 1984 Dec; 61(6):772-5. PubMed ID: 6507932
[No Abstract] [Full Text] [Related]
27. Identification of susceptibility to malignant hyperpyrexia.
Moulds RF; Denborough MA
Br Med J; 1974 May; 2(5913):245-7. PubMed ID: 4827071
[TBL] [Abstract][Full Text] [Related]
28. Malignant hyperthermia associated with enflurane anesthesia.
Caropreso PR; Gittleman MA; Reilly DJ; Patterson LT
Arch Surg; 1975 Dec; 110(12):1491-3. PubMed ID: 1200833
[TBL] [Abstract][Full Text] [Related]
29. Unexpected hyperthermia manifesting during outpatient anesthesia.
Braude BM; Press P; Moyes DG; Isaacs H; Danilewitz MD; Kolb ME
Anesthesiology; 1986 May; 64(5):647-50. PubMed ID: 3963484
[No Abstract] [Full Text] [Related]
30. New Zealand Committee on Adverse Drug Reactions. Eighth annual report.
N Z Med J; 1973 Oct; 79(500):309-16. PubMed ID: 4519120
[No Abstract] [Full Text] [Related]
31. Histopathological and neuropharmacological aspects of malignant hyperpyrexia.
Ellis FR; Keaney NP; Harriman DG
Proc R Soc Med; 1973 Jan; 66(1 Pt 1):66-7. PubMed ID: 4690061
[No Abstract] [Full Text] [Related]
32. A protocol to manage malignant hyperthermia with general anesthesia.
Roberts MW
Pediatr Dent; 1993; 15(1):45-6. PubMed ID: 7901841
[No Abstract] [Full Text] [Related]
33. [Malignant hyperthermia--clinical aspects and treatment of life-endangering complications of anesthesia].
Purschke R; Zindler M
Chirurg; 1974 Oct; 45(10):472-6. PubMed ID: 4462988
[No Abstract] [Full Text] [Related]
34. Malignant hyperthermia.
Kalow W
Proc R Soc Med; 1970 Feb; 63(2):178-80. PubMed ID: 5440755
[No Abstract] [Full Text] [Related]
35. [Limited anesthetic possibilities in patients with hereditary muscular diseases].
Althoff H
Z Rechtsmed; 1973 Apr; 72(2):128-39. PubMed ID: 4733606
[No Abstract] [Full Text] [Related]
36. Malignant hyperthermia in a family: a clinical and serological investigation of 139 members.
Kelstrup J; Reske-Nielsen E; Haase J; Jorni J
Acta Anaesthesiol Scand; 1974; 18(1):58-64. PubMed ID: 4836147
[No Abstract] [Full Text] [Related]
37. [Malignant hyperthermia].
Pöntinen PJ; Abele K; Autere T
Duodecim; 1974; 90(1):55-8. PubMed ID: 4849136
[No Abstract] [Full Text] [Related]
38. Biochemical studies on malignant hyperpyrexia.
Pennington RJ; Worsfold M
Proc R Soc Med; 1973 Jan; 66(1 Pt 1):69-70. PubMed ID: 4266079
[No Abstract] [Full Text] [Related]
39. Clinical, electrophysiological and pathological studies on malignant hyperpyrexia.
Bradley WG; Ward M; Murchison D; Hall L; Woolf N
Proc R Soc Med; 1973 Jan; 66(1 Pt 1):67-8. PubMed ID: 4690062
[No Abstract] [Full Text] [Related]
40. [Syndrome of malignant hyperthermia].
Kacinec J; Malatinský J; Sadlon P; Klimasová A
Rozhl Chir; 1974 Nov; 53(11):734-9. PubMed ID: 4439083
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
